Literature DB >> 26981944

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Robert Rosenstein1, Augustus Hough1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26981944     DOI： 10.1056/NEJMc1600827

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Efficacy and Safety of Mulberry Twig Alkaloids Tablet for the Treatment of Type 2 Diabetes: A Multicenter, Randomized, Double-Blind, Double-Dummy, and Parallel Controlled Clinical Trial.

Authors:  Ling Qu; Xiaochun Liang; Guoqing Tian; Gaili Zhang; Qunli Wu; Xiumei Huang; Yazhong Cui; Yuling Liu; Zhufang Shen; Changqing Xiao; Yingfen Qin; Heng Miao; Yongyan Zhang; Ziling Li; Shandong Ye; Xuezhi Zhang; Jing Yang; Guiwen Cao; Yi Li; Gangyi Yang; Ji Hu; Xiaoyue Wang; Zhengfang Li; Yukun Li; Xiuzhen Zhang; Guangde Zhang; Li Chen; Wenjin Hua; Ming Yu; Chunyan Lu; Xiaomei Zhang; Hong Jiang
Journal:  Diabetes Care       Date:  2021-04-08       Impact factor: 17.152

2.  Empagliflozin Attenuates Hyperuricemia by Upregulation of ABCG2 via AMPK/AKT/CREB Signaling Pathway in Type 2 Diabetic Mice.

Authors:  Yun-Hong Lu; Yun-Peng Chang; Ting Li; Fei Han; Chun-Jun Li; Xiao-Yu Li; Mei Xue; Ying Cheng; Zi-Yu Meng; Zhe Han; Bei Sun; Li-Ming Chen
Journal:  Int J Biol Sci       Date:  2020-01-01       Impact factor: 6.580

3.  Dapagliflozin Ameliorates STZ-Induced Cardiac Hypertrophy in Type 2 Diabetic Rats by Inhibiting the Calpain-1 Expression and Nuclear Transfer of NF-κB.

Authors:  Lei Liu; Haizhao Luo; Yunyi Liang; Jielong Tang; Yi Shu
Journal:  Comput Math Methods Med       Date:  2022-01-20       Impact factor: 2.238

4.  Beta-Hydroxybutyrate, Friend or Foe for Stressed Hearts.

Authors:  Yuxin Chu; Cheng Zhang; Min Xie
Journal:  Front Aging       Date:  2021-06-08

Review 5.  Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary.

Authors:  Annamaria Mascolo; Raffaella Di Napoli; Nunzia Balzano; Donato Cappetta; Konrad Urbanek; Antonella De Angelis; Lucia Scisciola; Irene Di Meo; Maria Giuseppa Sullo; Concetta Rafaniello; Liberata Sportiello
Journal:  Front Cardiovasc Med       Date:  2022-09-21

Review 6.  Ketone body metabolism in diabetic and non-diabetic heart failure.

Authors:  Ningjing Qian; Yaping Wang
Journal:  Heart Fail Rev       Date:  2020-09       Impact factor: 4.214

7.  Treatment Effect of Type 2 Diabetes Patients in Outpatient Department Based on Blockchain Electronic Mobile Medical App.

Authors:  Yang Liu; Zhaoxiang Yu; Hua Sun
Journal:  J Healthc Eng       Date:  2021-03-01       Impact factor: 2.682
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.